Selenium supplementation for critically ill adults (Q24246013)

1

object named as

Alison Avenell

0 references

author name string

David W Noble

2

0 references

John Barr

3

0 references

Thomas Engelhardt

Cochrane Database of Systematic Reviews

4

0 references

publication date

18 October 2004

0 references

published in

0 references

cites work

Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Selenium administration in sepsis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Effect of selenium supplementation on biochemical markers and outcome in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Limited effects of micronutrient supplementation on strength and physical function after abdominal aortic aneurysmectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Practicalities of selenium supplementation in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Antioxidants in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Selenium in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Assessment of outcome after severe brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Ebselen: prospective therapy for cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

The importance of selenium to human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Selenium: an acute-phase reactant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Predicting discharge status at commencement of stroke rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

Total parenteral nutrition in the critically ill patient: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

7 January 2021

[Selenium administration in patients with sepsis syndrome. A prospective randomized study]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

7 January 2021

[Selenium administration in severe inflammatory surgical diseases and burns in childhood]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

7 January 2021

[Effect of selenium administration on various laboratory parameters in patients with acute pancreatitis]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

7 January 2021

[Selenium substitution in acute myocardial infarct]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

7 January 2021

[Molecular biology studies of a multicenter phase III study (SIC Study)]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

7 January 2021

[Investigation of antioxidant therapy with sodium selenite in acute pancreatitis. A prospective randomized blind trial]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

7 January 2021

Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

7 January 2021

Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

7 January 2021

Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003703.PUB2

7 January 2021